Skip to main content
Menu

Eonis SCID-SMA kit

A PCR kit designed for the quantitative determination of Severe Combined Immunodeficiency (SCID) and x-linked Agammaglobulinemia (XLA), as well as the qualitative detection of Spinal Muscular Atrophy (SMA) using newborn dried blood spot samples.
A PCR kit designed for the quantitative determination of Severe Combined Immunodeficiency (SCID) and x-linked Agammaglobulinemia (XLA), as well as the qualitative detection of Spinal Muscular Atrophy (SMA) using newborn dried blood spot samples.
Product variant
Unit Size: 384 reactions
Part #:
3241-0020
For in vitro diagnostic use. This product is only available where licensed in accordance with law. Please contact your local representative for availability.
Request more information

Overview

The Eonis™ SCID-SMA kit is intended for the semi-quantitative determination of TREC (T-cell receptor excision circle) and KREC (Kappa-deleting recombination excision circle) as well as the qualitative detection of the exon 7 SMN1 gene and RPP30 (Ribonuclease P/MRP Subunit P30) gene in DNA from blood specimens dried on a filter paper as an aid in screening newborns for Severe Combined Immunodeficiency (SCID), X-linked agammaglobulinemia (XLA), and Spinal Muscular Atrophy (SMA).

Specifications

Brand
Eonis™
Detection Modality
qPCR
Disorders
SCID
SMA
Instrument Compatibility
EONIS System
Regulatory Status
CE-IVD marked
Sample Type
Dried blood spots
Technology
qPCR
Unit Size
384 reactions

Resources

Are you looking for resources, click on the resource type to explore further.

Scroll Icon

Revvity AI Assistant Beta